Does EmbryoGlue transfer medium affect embryo transfer success rate?

Česká verze

Authors: B. Zbořilová ^1,2; I. Oborná ^1,3; E. Tkadlec ^4,5; M. Procházka ^1,6; J. Březinová ⁷; A. Sobek jr. ¹; A. Sobek ¹
Authors place of work: Fertimed, Olomouc/Polanka nad Odrou, vedoucí doc. MUDr. A. Sobek, CSc. ¹; Ústav biologie LF UP, Olomouc, přednosta doc. RNDr. V. Divoký, Ph. D. ²; Porodnicko-gynekologická klinika LF UP a FN, Olomouc, přednosta prof. MUDr. R. Pilka, Ph. D. ³; Katedra ekologie a životního prostředí PřF UP, Olomouc, vedoucí katedry prof. MVDr. E. Tkadlec, CSc. ⁴; Ústav biologie obratlovců AV ČR, Studenec, ředitel doc. Ing. M. Honza ⁵; Ústav lékařské genetiky FN, Olomouc, přednosta prof. MUDr. M Procházka ⁶; SpermBank International, Olomouc, JUDr. M. Polach ⁷
Published in the journal: Ceska Gynekol 2018; 83(3): 177-181

Summary

Objective:

Verification of the effect of EmbryoGlue (EG) transfer medium enriched with hyaluronan on the embryo transfer success rate.

Design:

A prospective study.

Setting:

Fertimed, Fertility Treatment Centre, Olomouc.

Methods:

484 patients undergoing IVF + ET were engaged who were divided according to the medium used during transfer: Sage or Vitrolife culture medium (n = 135) and EG transfer medium (n = 349). The influence of other factors was also evaluated: age, number of received oocytes, percentage of fertilised oocytes, endometrium height on the day of transfer, number of preserved embryos, number of transferred embryos and the length of cultivation (48, 72, 96, 120 h). These factors were considered quantitative variables while the method of hormone stimulation, the type of culture medium and the application of EG were considered qualitative (categorical) variables.

Results:

With the use of EG the chances of conception increased by approximately 9%. The negative effect of higher age on implantation proportion and the positive effect of cultivation prolongation were proven. The effect of EG on miscarriages was not proven. The probability of miscarriage diminished with higher oocyte fertilisation. The culture medium used (Sage or Vitrolife) before the application of EG does not affect the gravidity result.

Conclusion:

Using the transfer medium of EmbryoGlue before embryo transfer affects the pregnancy rate (PR) in a positive manner. The influence on pregnancy loss with the application of EG was not proven.

Keywords:

EmbryoGlue, hyaluronan, IVF, in vitro fertilisation

Zdroje

1. Balaban, B., Urman, B., Yakin, K., et al. High pregnancy and implantation rates can be achieved in blastocyst transfers using hyaluronan enriched culture and transfer médium. Fertil Steril, 2004, 82, Suppl. 2, p. 221.

2. Bontekoe, S., Johnson, N., Blake, D. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane Database of Systematic Reviews 2014, Issue 2.

3. Burnham, KP, Anderson, DR. Model selection and multimodel inference. a practical information-theoretic approach, 2nd ed. New York, USA, Springer, 2002.

4. Carson, DD., Dutt, A., Tang, JP. Glycoconjugate synthesis during early pregnancy: hyaluronate synthesis and function. Dev Biol, 1987, 120, p. 228–235.

5. Gardner, DK., Rodriegez-Martinez, H., Lane, M. Fetal development after transfer is increased by replacing protein with the glycosaminoglykan hyaluronan for mouse embryo culture and transfer. Hum Reprod, 1999, 14, p. 2575–2580.

6. Fancsovits, P., Murber, A., Tothne Gilan, Z., et al. Effect of hyaluronan containing transfermedia on pregnancy and implantation rates in human IVF-ET cycles. A prospective randomized study. Hum Reprod, 2011, 26, p. 24.

7. Fancsovits, P., Lehner, A., Murber, A., et al. Effect of hyaluronan-enriched embryo transfer médium on IVF outcome: A prospective randomized clinical trial. Arch Gynecol Obstet, 2015, 291, p. 1173–1179.

8. Friedler, S., Schachter, M., Strassburger, D., et al. A randomized clinical trial csparing recombinant hyaluronan/recombinant albumin versus human tubal fluid for cleavage stage embryo transfer in patients with multiple IVF-embryo transfer failure. Hum Reprod, 2007, 22, p. 2444–2448.

9. Hambiliki, F., Ljunger, E., Karlström, PO., Stavreus-Evers, A. Hyaluronan-enriched transfer médium in cleavage-stage frozen-thawed embryo transfers increases implantation rate without improvement of delivery rate. Fertil Steril, 2010, 94, p. 1669–1673.

10. Hazlett, WD., Meyer, LR., Nasta, TE., et al. Impact of EmbryoGlue as the embryo transfer médium. Fertil Steril, 2008, 90, p. 214–216.

11. Kano, K., Miyano, T., Kato, S. Effects of glycosaminoglycans on the development of in vitro-matured and fertilized porcine oocytes to the blastocyst stage in vitro. Biol Reprod, 1998, 58, p. 1226–1232.

12. Korosec, S., Virant-Klun, I., Tomazevic, T., et al. Single freshand frozen-thawed blastocyst transfer using hyaluronan-rich transfer médium. Reprod Biomed Online, 2007, 15, p. 701–707.

13. Leese, HJ. Formation and function of oviduct fluid. J Reprod Fertil, 1988, 82, p. 843–856.

14. Loutradi, KE., Prassas, I., Bili, E., et al. Evaluation of a transfer médium containing high concentration of hyaluronan in human in vitro fertilization. Fertil Steril, 2007, 87, p. 48–52.

15. Mahani, IM., Davar, R. Hyaluronic acid versus albumin inhuman embryo transfer médium. Eastern Mediterranean Health J, 2007, 13, p. 876–880.

16. Nakagawa, K., Takahashi, C., Nishi, Y., et al. Hyaluronan-enriched transfer médium improves outcome in patients with multiple embryo transfer failures. J Assist Reprod Genet, 2012, 29, p. 679–685.

17. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2017.

18. Ravhon, A., Nahum, H., Weissman, A., et al. Embryo transfer in hyaluronan enrichedtransfer médium does not improve pregnancy rate in IVF treatment. Fertil Steril, 2005, 84, p. 376–377.

19. Salustri, A., Camaioni, A., Di Giacomo, M., et al. Hyaluronan and proteoglycans in ovarian follicles. Hum Reprod UpDate, 1999, 5, p. 293–301.

20. Scott, JE., Heatley, F. Biological properties of hyaluronan in aqueous solution are controlled and sequestered by reversible tertiary structures, defined by NMR spectroscopy. Biomacromolecules, 2002, 3, p. 547–553.

21. Schoolcraft, W. Increased hyaluronan concentration in the embryo transfer médium results in a significant increase in human embryo implantation rate. Fertil Steril, 2002, 76, Suppl., p. 1–11.

22. Simon, A., Safran, A., Revel, A., et al. Hyaluronic acid can successfully replace albumin as the sole macromolecule in a human embryo transfer médium. Fertil Steril, 2003, 79, p. 1434–1438.

23. Singh, N., Gupta, M., Kriplani, A., Vanamail, P. Role of Embryo Glue as a transfer médium in the outcome of fresh non-donor in-vitro fertilization cycles. J Hum Reprod Sci, 2015, 8, p. 214–217.

24. Svobodova, M., Březinova, J., Oborna, I., et al. Transferové médium s hyaluronanem EmbryoGlue v programu IVF + ET. Čes Gynek, 2007, 72, s. 15–19.

25. Turley, E., Moore, D. Hyaluronate binding proteins also bind to fibronectin, laminin and collagen. Biochem Biophys Res Commun, 1984, 121, p. 808–814.

26. Urman, B., Yakin, K., Ata, B., et al. Effect of hyaluronan-enriched transfer médium on implantation and pregnancy rates after day 3 and day 5 embryo transfers: A prospective randomized study. Fertil Steril, 2008,90, p. 604–612.

27. Yanagishita, M. Proteoglycans and hyaluronan in female reproductive organs. Proteoglycans, 1994, 70, p. 179–190